BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 347546)

  • 1. [Immunological aspects of malignant lymphomas].
    Hancock BW; Richmond J
    Recenti Prog Med; 1978 Feb; 64(2):217-29. PubMed ID: 347546
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunity in Hodgkin's lymphoma].
    Danieli G; Montroni M; Leoni P; Magelli L; Totti S
    G Clin Med; 1975; 56(1):39-56. PubMed ID: 770222
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunity and hypersensitivity in Hodgkin's lymphoma].
    Leoni P; Marchegiani G; Montillo M; Centurioni R; Montroni M; Danieli G
    Minerva Med; 1982 May; 73(20):1361-9. PubMed ID: 6210855
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunodeficiencies in Hodgkin's Disease. Part II: B cell immunity, complement systems and phagocytic cell systems.
    Gupta S
    Clin Bull; 1981; 11(3):110-9. PubMed ID: 7039866
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunological characteristics of malignant skin lymphomas].
    Shaposhnikov OK; Rodionov AN
    Vestn Dermatol Venerol; 1982 Mar; (3):4-11. PubMed ID: 6978580
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunodeficiencies and lymphomas].
    Montroni M
    Minerva Med; 1982 Apr; 73(15):929-34. PubMed ID: 7043315
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunological aspects of Hodgkin's disease].
    Bianchini E
    Minerva Med; 1975 Feb; 66(8):365-70. PubMed ID: 1078722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immediate effects of splenectomy, radiotherapy and intensive chemotherapy on the immune status of patients with malignant lymphoma.
    Hancock BW; Bruce L; Ward AM; Richmond J
    Clin Oncol; 1977 Jun; 3(2):137-44. PubMed ID: 872467
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunological aspects of chronic diseases].
    Lozovoĭ VP
    Vestn Akad Med Nauk SSSR; 1975; (10):23-9. PubMed ID: 1108497
    [No Abstract]   [Full Text] [Related]  

  • 10. [Lymphomas and immunity].
    Kouvalainen K
    Duodecim; 1970; 86(16):886-94. PubMed ID: 4917099
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro characterization of T and B lymphocytes in chronic lymphatic leukemia and Hodgkin's disease.
    Tursi A; Ferrannini A; Losito G
    Boll Ist Sieroter Milan; 1974; 53(1):suppl:306. PubMed ID: 4604590
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunity, leukemias and lymphomas. VI. Immunological state of splenectomized patients with malignant granuloma, in relation to the histological type of the disease].
    Danieli G; Malini PL; Montroni M; Cremonini G; Lauria F
    G Clin Med; 1972 Jul; 53(7):334-43. PubMed ID: 4666411
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunological deficiency and malignant lymphoma.
    Miller DG
    Cancer; 1967 Apr; 20(4):579-88. PubMed ID: 5227107
    [No Abstract]   [Full Text] [Related]  

  • 14. [Autoimmune diseases - immunological bases].
    Jäger L
    Z Gesamte Inn Med; 1975 Nov; 30(21):239-40 contd. PubMed ID: 55001
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of haematological malignancies and their treatment on host defence factors.
    Hersh EV; Gutterman JU; Mavligit GM
    Clin Haematol; 1976 Jun; 5(2):425-48. PubMed ID: 780032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biology and differentiation of lymphocytes in the classification of lymphomas].
    Mariuzzi G; Di Loreto C; Mariuzzi L
    Recenti Prog Med; 1990 Oct; 81(10):621-8. PubMed ID: 2291005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defence systems of the body, immunosuppression and immunotherapy.
    James DG
    J R Nav Med Serv; 1976; 62(2):60-72. PubMed ID: 787517
    [No Abstract]   [Full Text] [Related]  

  • 18. Monitoring of colon cancer through measurement of carcinoembroyonic antigen levels, tests of cellular immune competence, and tumor specific immunity.
    Holyoke ED; Goldrosen MH
    Int Adv Surg Oncol; 1978; 1():85-111. PubMed ID: 399765
    [No Abstract]   [Full Text] [Related]  

  • 19. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.
    Gajl-Peczalska KJ; Hansen JA; Bloomfield CD; Good RA
    J Clin Invest; 1973 Dec; 52(12):3064-73. PubMed ID: 4201499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Primary antibody formation in patients with malignant diseases of the lymphoreticular system and with metastasizing tumors (author's transl)].
    Krull P; Deicher H
    Z Immunitatsforsch Exp Klin Immunol; 1973 Mar; 145(1):70-7. PubMed ID: 4282946
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.